Abstract:
Fragile X syndrome is a genetic condition often associated with autism, learning disabilities, and seizure disorders. UNC is one of the few hospitals in the United States enrolling patients in clinical trials for treatment. Preliminary results of the new treatment show reduced symptoms and improved cognitive ability.